The Research Advocacy Network is seeking lung cancer survivors who have received chemotherapy to share their experience about certain side effects in an online survey.

Individuals diagnosed with lung cancer who have received chemotherapy are invited to begin the survey at http://bit.ly/1yXAfFr. Participants will first be asked about certain characteristics of their experience. Participants who are invited to take the full survey and complete all the responses will be offered an incentive for their participation. The full survey will take about 20 minutes to complete. Responses are anonymous. The survey will help doctors and nurses improve patient care.

Other ways to help:

• If you are a member of a lung cancer support group, please share this opportunity with the group.
• If you are a member of an online discussion forum for lung cancer survivors (Inspire, etc.), please post this opportunity for others to see.
• If you have not had lung cancer but know of someone who has, please share this opportunity with them.

For more information about this survey, contact the Research Advocacy Network at info@researchadvocacy.org.

About The Research Advocacy Network:

The mission of the Research Advocacy Network is to develop a network of advocates and researchers who influence cancer research – from initial concept to patient care delivery — through collaboration, education and mutual support.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has initiated more than 150 trials in a variety of cancer types and supportive care, resulting in more than 300 publications. More than 4,600 subjects have participated in Hoosier Cancer Research Network clinical trials.